Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Highland Ophthalmology Establishes a Dry Eye Center of Excellence in the Hudson Valley of New York
  • USA - English


News provided by

Bestel & Associates

Sep 27, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX

New Windsor, New York (PRWEB) September 27, 2016 -- Highland Ophthalmology Associates, LLC (http://www.highlandophthalmology.com), a leading specialty eye care center, announced today the establishment of a Dry Eye Center of Excellence at its state-of-the-art eye care facility in New Windsor, New York. The Dry Eye Center of Excellence offers patients a comprehensive array of advanced, proven technologies to diagnose and treat chronic Dry Eye Syndrome.

It is estimated more than 23 million people over the age of 20 suffer from chronic dry eye.  In many cases, the root cause is Meibomian Gland Dysfunction (MGD), also known as Evaporative Dry Eye. The condition occurs when the Meibomian glands, which are responsible for producing the oil layer in tears, do not function properly. “Chronic Dry Eye Syndrome must be properly diagnosed and managed. If left untreated, chronic dry eye often becomes so uncomfortable that patients must make lifestyle adjustments and it can impact one’s vision and eye health,” said Dr. Mary Davidian, Founder and Medical Director of Highland Ophthalmology.

The suite of innovative solutions utilized by the eye care team at Highland Ophthalmology includes LipiView®, LipiFlow®, ProKera® and Prokera Clear, Avenova and HydroEye®, to name a few.

Thorough Evaluation
Patients reporting acute symptoms of dry eye are evaluated first with a thorough slit lamp examination, and then by using state-of-the-art diagnostic LipiView® technology. This non-invasive imaging procedure, which takes less than five minutes, captures detailed images of the tear film to identify any gland blockage and atrophy and allows doctors to determine if a patient exhibits Meibomian Gland Dysfunction.

Innovative Technology
Highland Ophthalmology is the first practice in the New Windsor area to offer LipiFlow®, a new, breakthrough system for assessing and treating Evaporative Dry Eye. While many traditional dry eye treatment options like warm compresses, eye drops and ointments have been available for years, they do not address the root cause of the condition. Many of these treatments have been proven ineffective in providing relief for some patients. The revolutionary LipiFlow® system uses warm heat and pressure to unblock Meibomian glands, allowing tears to comfort the eye and provide relief. This in-office procedure takes less than 15 minutes and relieves symptoms for up to 12 months. It is rapidly becoming the new standard of care for treating the cause and not just the effects of chronic dry eye.

ProKera® is a biologic corneal bandage lens containing amniotic membrane tissue that is the only FDA cleared therapeutic medical device that reduces inflammation and promotes ocular healing. Since dry eye disease is often inflammatory in etiology, this unique device has proven to be markedly beneficial in providing ocular comfort to patients who are currently using multiple treatment modalities, but are still suffering from symptoms of dryness. More recently, the Biotissue Company has introduced the Prokera Clear which allows for maintenance of the patient’s vision during treatment, due to the presence of the central Clear-View Aperture. Prokera Clear® is ideal for ambulatory, chronic ocular surface disease, corneal-involved dry eye patients, and post Lasik/PRK patients. Sutureless and adhesiveless, ProKera® is a safe and effective method to promote healing and reconstruction of the ocular surface and orbit with minimal side effects.  

HydroEye® is a patented nutritional formulation that works from the inside out to provide continuous support for dry eyes. HydroEye®, the focus of new research, delivers a proprietary blend of omega fatty acids (GLA, EPA and DHA), antioxidants and other key nutrients that work together to support a healthy tear film and soothe the ocular surface.

Avenova® with Neutrox® is the only non-detergent based, prescription eyelid and lash hygiene product containing pure hypochlorous acid, an active antibacterial, antifungal and virucidal compound. In addition, it exhibits anti-inflammatory activity by neutralizing inflammatory mediators in the body. By effectively treating eyelid inflammation, Avenova is an essential part of our treatment armamentarium helping to address the multifactorial etiology of Dry Eye Disease.

Team of Specialists
Patients at Highland Ophthalmology can take confidence in knowing their vision needs will be addressed by well-trained, dedicated physicians and specialists. Each patient’s unique needs are carefully evaluated using the most advanced testing equipment in order to develop a customized treatment plan.

Advancing Knowledge in our Community
The Center’s reputation for excellence is also underscored by the number of eye care practitioners who refer their advanced Dry Eye Patients to our group of specialists. Through this collaboration, local doctors have the advanced knowledge needed to help their patients and guide them on the advanced treatment options now available.
About Highland Ophthalmology Associates, LLC

Highland Ophthalmology Associates has been providing specialty eye care services in Orange County, NY and the Greater Hudson Valley area since 1997. As a highly established eye care center, the primary goal of Highland Ophthalmology Associates is to provide patients with personalized eye care, including the latest technology in Cataract, Cornea, Dry Eye and Glaucoma treatment. Highland Ophthalmology has assembled a team of some of the country’s finest ophthalmologists and optometrists, making the Hudson Valley a destination for people who want the best in eye care and vision correction.

The medical team of highly respected and devoted specialists is comprised of Dr. Mary Davidian, Dr. Thien (Tim) Huynh, Dr. Julia Mathew, Dr. Sharon Powell and Dr. Michael J. Stagner. The medical doctors of Highland Ophthalmology Associates are affiliated with leading medical and academic centers in the Hudson Valley and Greater New York Metropolitan Area, including the New York Eye and Ear Infirmary, Westchester Medical Center, Central New York Eye Center, Eastern Orange Ambulatory Surgery Center and Vassar Brothers Medical Center. For more information please visit http://www.highlandophthalmology.com.

Media Contact:

Nancy Ingersoll
+1 845-562-0138
[email protected]

ROBIN BESTEL, Bestel & Associates, +1 (610) 428-5845, [email protected]

Modal title

Logo
Logo
Dr. Mary Davidian
Dr. Mary Davidian
Logo Dr. Mary Davidian

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.